Advertisement

Topics

deCODE chemistry Company Profile

20:08 EDT 21st June 2018 | BioPortfolio

deCODE chemistry offers chemistry-based drug discovery and development services including early-stage lead discovery and optimization, process chemistry research for development of optimal synthetic routes, and cGMP production of materials in quantities for pre-clinical and clinical studies. Additionally, deCODE chemistry now offers services for evaluation of pharmaceutical properties including rapid identification of the best excipients to solubilize your compounds and assistance in formulation development to further optimize your compounds for use in pre-clinical and clinical studies.

Location

2501 Davey Road
Woodridge
Illinois
60517
United States of America

Contact

Phone: 1 (630) 783-4600
Fax: 1 (630) 783-4909


News Articles [271 Associated News Articles listed on BioPortfolio]

Microwave Chemistry Research Heats Up at WVU

Researchers seek to harness microwave energy strategically to expand the capabilities of organic chemistry, including to process optimization and green chemistry

Automated Chemistry: A Vision

I enjoyed this article at Chemistry World, but fair warning: you may not. I say that based on the response when I’ve written about its subject here before, which is the automation of synthetic ...

Raising the Profile of Chemistry: How to STEM the Recruitment Crisis

ArticleAlthough the chemistry industry makes invaluable contributions, many of these achievements are made behind the scenes and are not widely publicized.

deCODE genetics Inc Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 15022018] Prices from USD $350

deCODE genetics Inc Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's deCODE genetics Inc Mergers Acquisitions MA, Partnerships Alliances and Investments re...

John E. Sulston, Nobel-winning scientist who helped decode human genome, dies at 75 – Washington Post

Washington PostJohn E. Sulston, Nobel-winning scientist who helped decode human genome, dies at 75Washington PostJohn E. Sulston, a scientist who won the Nobel Prize for work on one of the lowliest of...

New Chemistry, And Its Limits

Here’s an article in Nature Chemistry on organic synthesis and drug discovery, from a distinguished group of drug-industry chemists. The authors are going over a number of areas where medicinal ...

Flow Chemistry System

Product AnnouncementThe Asia flow chemistry system from Syrris is helping researchers develop novel integrated systems for medicinal chemistry programs.

Taking a flow chemistry approach to medicinal programmes

The versatile Asia flow chemistry system from Syrris is helping researchers at the University of Perugia, Italy, to develop novel integrated systems for medicinal chemistry programmes

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Urea [Exact-Rx, Inc.]

Urea Cream 50% (in a cream base) Rx Only

Urea [Exact-Rx, Inc.]

Urea Cream 45%

PubMed Articles [493 Associated PubMed Articles listed on BioPortfolio]

Decoding the centromeric nucleosome through CENP-N.

Centromere protein (CENP) A, a histone H3 variant, is a key epigenetic determinant of chromosome domains known as centromeres. Centromeres nucleate kinetochores, multi-subunit complexes that capture s...

Particulate matters: student-led air quality research in the third-year environmental chemistry classroom and the field.

Bioorthogonal chemistry in bioluminescence imaging.

Bioorthogonal chemistry has developed significant over the past few decades, to the particular benefit of molecular imaging. Bioluminescence imaging (BLI) along with other imaging modalities have sign...

Correction to "Diverting Reactive Intermediates Toward Unusual Chemistry: Unexpected Anthranil Products from Davis-Beirut Reaction".

Data Handling in NMR Facilities and Assignment of NMR Spectra in Synthetic Chemistry Labs: Why Electronic Structure Validation should become Part of the Routine.

Clinical Trials [121 Associated Clinical Trials listed on BioPortfolio]

Effect of GlucoNorm vs Glyburide on Post-Prandial Hyperglycemia in Elderly Subjects With Type 2 Diabetes

The results from the DECODE Study have shown that postprandial (1 - 2 hours after a meal) hyperglycemia (elevated blood sugar) is more common in elderly people with diabetes than younger p...

An Open Label Study to Assess the Effect of BLI800 on Safety and Clinical Chemistry Parameters

To evaluate and compare the effects on safety measures and clinical chemistry after BLI800 in two groups of patients and one group of healthy controls. The patient groups will be those wi...

Performance Evaluation of In-Vitro Diagnostic Device

This is an interim report for POC testing of skyla Clinical Chemistry Analyzer and four skyla Test Systems (ALB, BUN, GLU, and TP). The analyses are performed with skyla Clinical Chemistry...

Measuring Effects of Alcohol on Brain Chemistry

Background: - Studies show that alcohol changes the amount of many brain chemicals. These changes may be related to continued drinking, craving for alcohol, and relapse. This study will u...

Microgrid II - Electrocorticography Signals for Human Hand Prosthetics

Neurologic disease with loss of motor function is a major health burden. Brain-computer interfaces (BCI) are systems that use brain signals to power an external device, such as a communica...

Companies [652 Associated Companies listed on BioPortfolio]

deCODE chemistry

deCODE chemistry offers chemistry-based drug discovery and development services including early-stage lead discovery and optimization, process chemistry research for development of optimal synthetic r...

deCode

Based in Reykjavik, Iceland, deCODE genetics is a population-based genomics company conducting research into the inherited causes of common diseases. The company operates one of the most technological...

deCODE genetics Inc.

In January 2006 deCODE GENETICS Inc., acquired Urdur Verdanki Skuld, a privately-held cancer research firm. The acquisition enables deCODE to broaden and enhances its cancer program by applying deCODE...

deCODE genetics

deCODE is a biopharmaceutical company applying its discoveries in human genetics to the development of drugs for common diseases. deCODE is a global leader in gene discovery - our population approach ...

deCODE genetics, Inc.

More Information about "deCODE chemistry" on BioPortfolio

We have published hundreds of deCODE chemistry news stories on BioPortfolio along with dozens of deCODE chemistry Clinical Trials and PubMed Articles about deCODE chemistry for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of deCODE chemistry Companies in our database. You can also find out about relevant deCODE chemistry Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record